Two isoforms of 11␤-hydroxysteroid dehydrogenase (11␤HSD) are present in mammals. 11␤HSD1 interconverts biologically active cortisol and inactive cortisone, whereas 11␤HSD2 only converts cortisol to cortisone. Placental 11␤HSD has been proposed to protect the fetus from high level of maternal glucocorticoids. Although bidirectional activity of 11␤HSD has been demonstrated in homogenized human placental tissues, the tissue and cellular distribution of 11␤HSD1 has not been resolved. In this study, the cellular localization of 11␤HSD1 protein and levels of its messenger ribonucleic acid (mRNA) in human placenta and fetal membranes were determined by immunohistochemistry and Northern blot analysis, respectively. We found that 11␤HSD1 immunoreactivity was present in the placental extravillous intermediate trophoblasts, chorion trophoblasts, amnion epithelial cells, and stromal cells of the decidua vera. Positive staining was also observed in the endothelium of the blood vessels in both placental villous tissue and umbilical cord. However, in contrast to previous reports of immunoreactive 11␤HSD2 localization, 11␤HSD1 immunoreactivity was undetectable in placental syncytiotrophoblast. Using a human 11␤HSD1 complementary DNA as probe, a 1.5-kilobase mRNA transcript was detected in the chorion, amnion, and placental tissue, with the greatest amount in the chorion. In contrast, the 1.9-kilobase mRNA of 11␤HSD2 was observed only in the placenta, not in the chorion and amnion. The process of labor had no significant effect on levels of 11␤HSD1 or 11␤HSD2 mRNA in the chorion or placenta. We conclude that there is a striking difference in the tissue localization of 11␤HSD1 and 11␤HSD2 expression in the late gestation human placenta and fetal membranes, which may discretely determine the accessibility of bioactive glucocorticoid to specific cell types. (J Clin Endocrinol Metab 82: 300 -305, 1997) 
observed in the endothelium of the blood vessels in both placental villous tissue and umbilical cord. However, in contrast to previous reports of immunoreactive 11␤HSD2 localization, 11␤HSD1 immunoreactivity was undetectable in placental syncytiotrophoblast. Using a human 11␤HSD1 complementary DNA as probe, a 1.5-kilobase mRNA transcript was detected in the chorion, amnion, and placental tissue, with the greatest amount in the chorion. In contrast, the 1.9-kilobase mRNA of 11␤HSD2 was observed only in the placenta, not in the chorion and amnion. The process of labor had no significant effect on levels of 11␤HSD1 or 11␤HSD2 mRNA in the chorion or placenta. We conclude that there is a striking difference in the tissue localization of 11␤HSD1 and 11␤HSD2 expression in the late gestation human placenta and fetal membranes, which may discretely determine the accessibility of bioactive glucocorticoid to specific cell types. (J Clin Endocrinol Metab 82: 300 -305, 1997) A N 11␤-hydroxysteroid dehydrogenase (11␤HSD) is the enzyme responsible for the interconversion of biologically active glucocorticoids and their receptor-inactive 11-keto metabolites. Two isoforms of 11␤HSD are present in mammals (1) (2) (3) . 11␤HSD1 has oxoreductase activity, is distributed ubiquitously, although it is most abundant in the liver, and interconverts cortisol and cortisone, requiring NADP(H) as its cofactor (4, 5) . In contrast, 11␤HSD2 has only dehydrogenase activity and is NAD dependent. It is more regionally distributed, with highest abundance in the kidney, pancreas, and placenta (6 -10). 11␤HSD2 confers specificity of the mineralocorticoid receptor in the kidney and contributes to the placental barrier preventing the passage of maternal glucocorticoids into the fetal circulation by converting active cortisol to inactive cortisone (11) (12) (13) . Epidemiological studies have suggested that smaller babies have a higher incidence of cardiovascular diseases in adulthood (14, 15) , and this has been attributed by some investigators to excessive exposure to maternal glucocorticoids during fetal life as a result of a deficiency in placental 11␤HSD2 (13) .
Although the high affinity of 11␤HSD2 for cortisol is more suited to metabolizing maternal glucocorticoids reaching the placenta, conversion from cortisone to cortisol was clearly demonstrable in homogenized placental and chorionic tissues (16) . This activity is regarded as the predominant reaction catalyzed by 11␤HSD1 in intact cells (17) . The unique cortisolregenerating function of 11␤HSD1 might indicate that this enzyme plays some additional roles in pregnancy (18) . However, the pattern of tissue and cellular distribution of 11␤HSD1 activity and synthesis in the placenta and fetal membranes of human pregnancy has not been studied, nor is there information on the relative expression of 11␤HSD isoenzymes with labor. We hypothesized that within the placenta and fetal membranes, the distribution of 11␤HSD1 might differ from that reported for 11␤HSD2 (6) , thereby conferring discrete cellular availability of bioactive glucocorticoids. We, therefore, examined the localization of 11␤HSD1 and levels of its messenger ribonucleic acid (mRNA) in placenta and fetal membranes using immunohistochemistry and Northern blot analysis and compared these mRNA levels with those of 11␤HSD2 in patients in the presence or absence of labor.
Materials and Methods

Tissue collection
Human placentae, umbilical cords, and fetal membranes were collected from patients after term elective cesarean section in the absence of labor (CS) or after spontaneous vaginal term delivery (SL). Tissues were either fixed in 4% paraformaldehyde-0.2% glutaraldehyde (n ϭ 3 for CS; n ϭ 4 for SL) or snap-frozen in liquid nitrogen and stored at Ϫ70 C (n ϭ 9 for CS; n ϭ 10 for SL). Before freezing, the amnion was peeled away gently from the chorion to study these tissues separately. Frozen samples were used for Northern blot analysis after extraction of total RNA. Fixed tissues were washed and stored in 70% ethanol before embedding them in paraffin wax. The paraffin blocks were sectioned at 5 m for immunohistochemistry.
Immunohistochemistry analysis
Sections of placenta, umbilical cord, and fetal membranes were stained for immunoreactive 11␤HSD1 (IR-11␤HSD1) using the avidinbiotin peroxidase method (Vector ABC, Vector Laboratories, Burlingame, CA), as described previously (19, 20) . The polyclonal primary antibody was raised in rabbits against a synthetic peptide corresponding to amino acids 278 -289 from the deduced sequence of ovine 11␤HSD1 protein (21) . Western blot analysis using this antibody revealed a 34-kDa immunoreactive protein in homogenates from Chinese hamster ovary cells transfected with 11␤HSD1 complementary DNA (cDNA) (22) . The antibody was purified by affinity chromatography (22) and was used at a dilution of 1:450. To test the specificity of the antibody, the sections were also stained with primary antibody preabsorbed with excess 11␤HSD1 synthetic peptide. Sections were counterstained with Carazzi's hematoxylin and examined by light microscopy.
Total RNA extraction and Northern blot analysis
Total cellular RNA was extracted from placenta, chorion/decidua, and amnion using lithium chloride-urea (23) and quantified spectrophotometrically at 260 nm. The integrity of the RNA was assessed before Northern blot hybridization (24) , carried out using a specific human 11␤HSD1 cDNA generated in our laboratory (25) and an 11␤HSD2 cDNA (8) (courtesy of Dr. A. L. Albiston, Baker Medical Research Institute, Melbourne, Australia). A cDNA for mouse 18S ribosomal RNA (rRNA) was used as an internal standard to determine the relative amounts of RNA loaded into each well and the transfer efficiency.
The autoradiographs were scanned using a densitometer (Ultrascan XL LKB 2222-020, LKB Produkter, Bromma, Sweden) to determine the relative optical densities of 11␤HSD1, 11␤HSD2, and 18S rRNA hybridization signals. For each RNA sample, the signal for the transcripts was measured within the linear range of the densitometer, and the ratio of 11␤HSD1 or 11␤HSD2 mRNA signals to 18S rRNA was calculated.
Statistical analysis
All data are shown as the mean Ϯ sem. Statistical differences between labor and no labor groups were assessed by Student's t test. Differences in the levels of 11␤HSD1 and 11␤HSD2 mRNA in the placenta, chorion/ decidua, and amnion were assessed by one-way ANOVA. Statistical significance was set at P Ͻ 0.05.
Results
Distribution of IR-11␤HSD1
There were no obvious differences in the distribution and localization of IR-11␤HSD1 between tissues obtained at CS not in labor and those obtained after SL (Table 1) . IR-11␤HSD1 was undetectable in the syncytiotrophoblast of placental villi. Positive immunoreactivity for 11␤HSD1 was present in the extravillous intermediate trophoblasts and in the endothelial cells lining the fine branches of the umbilical blood vessels in the tertiary villi (Fig. 1 , A-C, and Table 1 ). Patchy staining for IR-11␤HSD1 was found in some of the amnion epithelial cells of the fetal membranes and in some of the fibroblasts within the subepithelial layer (Fig. 1D) . Strong cytosolic staining for 11␤HSD1 was present in the chorionic trophoblast layer and in many of the decidual stromal cells that were adherent to the chorion ( Fig. 1D and Table 1 ). IR-11␤HSD1 was consistently found in the amniotic epithelium surrounding the umbilical cord and in the endothelial cells lining the umbilical blood vessels (Fig. 1, E and  F) . It was not detected in the cells contained in the Wharton's jelly tissue (Fig. 1F) .
Preabsorption of the 11␤HSD1 antibody with excess synthetic 11␤HSD1 peptide completely eliminated staining from the placenta (Fig. 1G) , membranes, and umbilical cord (data not shown), thereby attesting to the specificity of the immunostaining response.
11␤HSD1 and 11␤HSD2 mRNA abundance
By Northern blot analysis, a 1.5-kilobase (kb) 11␤HSD1 mRNA was found in total RNA from term chorion/decidual tissue. A weak signal was detectable in the placenta and in some of the amnion samples. Statistically, the level of 11␤HSD1 mRNA in amnion and placenta was significantly less than that in the chorion/decidua (Fig. 2) . In contrast, using a human 11␤HSD2 cDNA as probe, 1.9-and 4.0-kb 11␤HSD2 mRNA transcripts were found in the placenta. Under the same conditions, we did not detect 11␤HSD2 transcripts in the chorion/decidua or amnion tissues (Fig. 2) .
There was no effect of labor on the levels of 11␤HSD1 mRNA in chorion/decidua or on levels of 11␤HSD mRNA in placenta, although there was substantial variability between specimens (Fig. 3, a and b) .
Discussion
Giannopoulos et al. (16) reported that there was increased conversion of cortisone to cortisol in homogenized human placental tissue toward term, although conversion from cortisol to cortisone predominated at all gestational ages. Further studies indicated that placental 11␤HSD was a reversible enzyme system, and there were at least two species of 11␤HSD in human placenta (26) . The present study demonstrated that IR-11␤HSD1 is present in the placenta. The cellular distribution of 11␤HSD1 to extravillous cytotropho- blasts and vascular endothelium is clearly different from that of 11␤HSD2, which is found only in the syncytiotrophoblast (6) . Assuming that our measurements of IR-11␤HSD1 are reflective of enzyme bioactivity, we suggest that the increased reductase activity of the placental tissue with gestational age is due to an increase in 11␤HSD1, as demonstrated in this study. 11␤HSD1 was localized to chorion trophoblasts and decidua vera in addition to the placenta. Previously, Stewart et al. (27) suggested that 11␤HSD1 activity in the chorion was probably due to decidual contamination because the enzyme was absent in decidua-free fused chorion obtained from a twin pregnancy. However, the strong positive staining of IR-11␤HSD1 and abundant 11␤HSD1 mRNA in chorion indicate that 11␤HSD1 activity in chorion reflects its local biosynthesis. There are variable amounts of decidua adherent to the chorion in specimens from different patients, and we cannot be certain whether interpatient differences in 11␤HSD1 mRNA reflect this or different levels of the enzyme in chorion. Our results support the suggestion of Stewart et al. (27) that human decidua in late pregnancy expresses 11␤HSD1.
Tanswell et al. (28) reported that human amnion contained increasing 11␤HSD activity during pregnancy, thereby potentially contributing to the rising cortisol concentrations of amniotic fluid. Others have suggested that term amnion has negligible 11␤HSD activity in vitro (29) . In the present study we found discrete populations of amniotic epithelial cells that were positive for IR-11␤HSD1, and we found IR-11␤HSD1 localized to cells with the appearance of fibroblasts in the subepithelial mesenchyme. 11␤HSD1 mRNA levels were variable in samples of amnion from different patients. It seems likely that the activity of 11␤HSD1 in the amnion depends in part on which area of the tissue is sampled in addition to patient variability. Of interest, the amniotic epithelial cells surrounding the umbilical cord and the endothelial cells of the umbilical vessels consistently stained for IR-11␤HSD1. This staining was consistent with the intense positive IR-11␤HSD1 in the endothelial cells of the terminal branches of umbilical blood vessels within the placental villae. Bidirectional activity of 11␤HSD in vascular smooth muscle cells of other parts of the body has been reported previously (30) . 11␤HSD in blood vessels is thought to influence vascular tone by metabolizing glucocorticoids reaching the vessel wall (31) . Effects of glucocorticoids on vascular tone may be direct or indirect through other vasoactive compounds produced in the vascular wall. Glucocorticoids can induce hypertension through either a direct effect on the blood vessel with increasing transmembrane Ca 2ϩ influx (32) or a permissive action to other vascular regulating hormones (33) . We speculate that the umbilical vascular 11␤HSD may have a similar role in regulating vascular tone in the umbilical cord and the placental villi, and this possibility seems worthy of further study. 3 . Effect of labor on the levels of A) 11␤HSD2 mRNA in human placenta (labor group, n ϭ 7; no labor group, n ϭ 5) and B) 11␤HSD1 mRNA in chorion/decidua of patients at term (labor group, n ϭ 10; no labor group, n ϭ 9). Each panel shows autoradiographs of Northern blots and densitometric levels relative to 18S rRNA. In A, 20 g total RNA were loaded per lane; in B, 30 g were loaded. The films were exposed for 24 h. There were no statistical differences between the labor and no labor groups (by Student's t test).
Consistent with our immunohistochemical results, a mRNA for 11␤HSD1 with an expected size of 1.5 kb (25) was detected in chorion, placenta, and amnion using a human 11␤HSD1 cDNA probe. This finding provides conclusive evidence that the enzyme is synthesized in these tissues. However, levels of 11␤HSD1 mRNA were much greater in chorion/decidua than in placenta and amnion, consistent with the more extensive IR-11␤HSD1 staining in chorion trophoblasts. Recently, 11␤HSD1 mRNA was demonstrated in the human placenta using reverse transcriptase-PCR (34), although previously the same researchers were unable to demonstrate 11␤HSD1 mRNA in this tissue (27) . The apparent differences in 11␤HSD1 mRNA between different studies and within individual patients may reflect heterogeneity of the tissue, particularly in the content of extravillous cytotrophoblasts, which are major sites of expression.
The highest levels of 11␤HSD2 mRNA were found in the placenta, as shown previously (27) . 11␤HSD2 mRNA was not detected in total RNA from the fetal membranes, further indicating the discrete cellular distribution patterns of 11␤HSD1 and 11␤HSD2 in the placenta and fetal membranes. In addition to the 1.9-kb 11␤HSD2 mRNA in placenta, we observed a larger transcript of about 4.0 kb. The presence of this transcript has been reported previously in the mouse kidney (35) . It is possible that the larger 4.0-kb transcript is the product of a distinct transcriptional start site within the 11␤HSD2 gene.
In humans, glucocorticoids have been shown to stimulate the synthesis of CRH from the placenta and membranes and to increase levels of placental CRH mRNA (20) . Glucocorticoids increase PG synthesis from confluent amnion epithelial cells (36) , and CRH and PGs have been implicated in causing uterine contractility, either directly or indirectly (37, 38) . Therefore, 11␤HSD in the placenta and fetal membranes could influence the process of labor by metabolizing glucocorticoids reaching the placenta and fetal membranes. However, the lack of change in 11␤HSD1 or 11␤HSD2 mRNA or 11␤HSD1 localization in either the fetal membranes or the placenta in association with labor implies that any influence of 11␤HSD1 on this process is not exerted acutely at the time of parturition, although we cannot preclude a progressive influence through late gestation (26, 39) .
Although the affinity of 11␤HSD1 is too low to effectively exclude maternal glucocorticoids from the fetus, the differential distributions of 11␤HSD1 and 11␤HSD2 in the placenta and fetal membranes and the unique cortisol regenerating function of 11␤HSD1 could provide a coordinated mechanism by which the amounts of maternal glucocorticoids reaching the fetus are controlled precisely. Understanding the discrete distribution and functions of 11␤HSD1 and 11␤HSD2 in the placenta and fetal membranes could be important in understanding not only the processes of normal pregnancy, but also the pathophysiology of abnormal pregnancy including preterm delivery, preeclampsia, and fetal growth restriction.
